2022年中国胸痛中心质控报告全国版

2022 年 中国胸痛中心 质控报告 Chest pain center of China quality report 组织编写单位：中国胸痛中心联盟 心血管健康联盟 中国医师协会胸痛专业委员会 1 目 录 摘要 第一部分 中国胸痛中心组织管理体系 ·································································· 5 第二部分 中国胸痛中心认证体系 ········································································ 7 一、中国胸痛中心认证标准 ······················································································· 8 二、中国胸痛中心建设与管理流程 ·············································································· 8 第三部分 中国胸痛中心质控体系 ········································································ 9 一、中国胸痛中心外部质控工作机制 ········································································· 10 二、中国胸痛中心常态化质控的有效工具 ··································································· 11 三、中国胸痛中心常态化质控工作进展 ······································································ 11 第四部分 中国胸痛中心建设情况 ······································································ 12 一、中国胸痛中心认证/建设数量 ·············································································· 13 二、各省胸痛中心建设情况 ····················································································· 13 1.各省二级以上医院胸痛中心建设比例（注册数量/二级以上医院数量）······················ 14 2.各省胸痛中心注册数量情况 ············································································· 14 3.各省胸痛中心认证数量情况 ············································································· 15 4.各省胸痛中心认证通过率（通过认证数量/注册总数） ··········································· 15 5.各省每百万常住人口胸痛中心数量 ···································································· 16 三、各省胸痛中心救治高危急性胸痛患者情况 ···························································· 16 四、标准版胸痛中心关键指标分析 ············································································ 18 1.全部 STEMI 患者发病到首次医疗接触（S2FMC）时间 ·········································· 18 2.行 PPCI 治疗的 STEMI 患者入门至导丝通过（D2W）时间 ····································· 19 3.全部 STEMI 患者来院方式 ·············································································· 20 4.发病 12h 以内 STEMI 患者接受再灌注治疗的比例 ················································ 21 5.STEMI 患者出院带药符合指南推荐的比例 ·························································· 23 6.STEMI 患者院内死亡率 ·················································································· 23 7.STEMI 患者平均住院天数 ··············································································· 25 8.STEMI 患者平均住院费用 ··············································································· 26 五、基层版胸痛中心关键指标分析 ············································································ 27 2 1.全部 STEMI 患者发病到首次医疗接触（S2FMC）时间 ·········································· 27 2.行 PPCI 治疗的 STEMI 患者入门至导丝通过（D2W）时间 ····································· 28 3.行溶栓治疗的 STEMI 患者入门至开始溶栓（D2N）时间 ······································· 30 4.全部 STEMI 患者来院方式 ·············································································· 31 5.发病 12h 以内 STEMI 患者接受再灌注治疗的比例 ········································